The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity
Open accessAbstract
Predicting clinical response to anticancer drugs remains a major challenge in cancer treatment. Emerging reports indicate that the tumour microenvironment and heterogeneity can limit the predictive power of current biomarker-guided strategies for chemotherapy. Here we report the engineering of personalized tumour ecosystems that contextually conserve the tumour heterogeneity, and phenocopy the tumour microenvironment using tumour explants maintained in defined tumour grade-matched matrix support and autologous patient serum. The functional response of tumour ecosystems, engineered from 109 patients, to anticancer drugs, together with the corresponding clinical outcomes, is used to train a machine learning algorithm; the learned model is then applied to predict the clinical response in an independent validation group of 55 patients, where we achieve 100% sensitivity in predictions while keeping specificity in a desired high range. The tumour ecosystem and algorithm, together termed the CANScript technology, can emerge as a powerful platform for enabling personalized medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033025 · Cited by 5,035
Liedtke, C., Mazouni, C., Hess, K. R., André, F., Tordai, A., Mejia, J. A., Symmans, W. F., Gonzalez-Angulo, A. M., Hennessy, B., Green, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.4147 · Cited by 2,892
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770
Systematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456
Van Cutsem, E., Peeters, M., Siena, S., Humblet, Y., Hendlisz, A., Neyns, B., Canon, J.-L., Van Laethem, J.-L., Maurel, J., Richardson, G., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.1620 · Cited by 1,979
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
Misale, S., Yaeger, R., Hobor, S., Scala, E., Janakiraman, M., Liska, D., Valtorta, E., Schiavo, R., Buscarino, M., Siravegna, G., et al. (2012) · Nature · doi:10.1038/nature11156 · Cited by 1,889
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Straussman, R., Morikawa, T., Shee, K., Barzily-Rokni, M., Qian, Z. R., Du, J., Davis, A., Mongare, M. M., Gould, J., Frederick, D. T., et al. (2012) · Nature · doi:10.1038/nature11183 · Cited by 1,771
Modeling Tissue Morphogenesis and Cancer in 3D
Yamada, K. M., & Cukierman, E. (2007) · Cell · doi:10.1016/j.cell.2007.08.006 · Cited by 1,751
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
Di Nicolantonio, F., Martini, M., Molinari, F., Sartore-Bianchi, A., Arena, S., Saletti, P., De Dosso, S., Mazzucchelli, L., Frattini, M., Siena, S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.0786 · Cited by 1,591
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Steidl, C., Lee, T., Shah, S. P., Farinha, P., Han, G., Nayar, T., Delaney, A., Jones, S. J., Iqbal, J., Weisenburger, D. D., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0905680 · Cited by 1,262
Majumder, P. K., Febbo, P. G., Bikoff, R., Berger, R., Xue, Q., McMahon, L. M., Manola, J., Brugarolas, J., McDonnell, T. J., Golub, T. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1052 · Cited by 964
Self-citationParacrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast
Scheel, C., Eaton, E. N., Li, S. H.-J., Chaffer, C. L., Reinhardt, F., Kah, K.-J., Bell, G., Guo, W., Rubin, J., Richardson, A. L., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.029 · Cited by 858
Weaver, V. M., Lelièvre, S., Lakins, J. N., Chrenek, M. A., Jones, J. C. R., Giancotti, F., Werb, Z., & Bissell, M. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00125-3 · Cited by 793
Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer
Kreso, A., O'Brien, C. A., van Galen, P., Gan, O. I., Notta, F., Brown, A. M. K., Ng, K., Ma, J., Wienholds, E., Dunant, C., et al. (2013) · Science · doi:10.1126/science.1227670 · Cited by 744
Sethi, T., Rintoul, R. C., Moore, S. M., MacKinnon, A. C., Salter, D., Choo, C., Chilvers, E. R., Dransfield, I., Donnelly, S. C., Strieter, R., et al. (1999) · Nature Medicine · doi:10.1038/9511 · Cited by 739
Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents
Sharma, S. V., Haber, D. A., & Settleman, J. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2820 · Cited by 586
Enabling personalized cancer medicine through analysis of gene-expression patterns
van 't Veer, L. J., & Bernards, R. (2008) · Nature · doi:10.1038/nature06915 · Cited by 554
Nakasone, E. S., Askautrud, H. A., Kees, T., Park, J.-H., Plaks, V., Ewald, A. J., Fein, M., Rasch, M. G., Tan, Y.-X., Qiu, J., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.017 · Cited by 478
Endocytosis of Receptor Tyrosine Kinases
Goh, L. K., & Sorkin, A. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a017459 · Cited by 461
In vitro fabrication of functional three-dimensional tissues with perfusable blood vessels
Sekine, H., Shimizu, T., Sakaguchi, K., Dobashi, I., Wada, M., Yamato, M., Kobayashi, E., Umezu, M., & Okano, T. (2013) · Nature Communications · doi:10.1038/ncomms2406 · Cited by 445
Oncogene addiction: setting the stage for molecularly targeted cancer therapy
Sharma, S. V., & Settleman, J. (2007) · Genes & Development · doi:10.1101/gad.1609907 · Cited by 441
Siena, S., Sartore-Bianchi, A., Di Nicolantonio, F., Balfour, J., & Bardelli, A. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp280 · Cited by 429
Kim, J., Takeuchi, H., Lam, S. T., Turner, R. R., Wang, H.-J., Kuo, C., Foshag, L., Bilchik, A. J., & Hoon, D. S. B. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.078 · Cited by 378
Foekens, J. A., Atkins, D., Zhang, Y., Sweep, F. C. G. J., Harbeck, N., Paradiso, A., Cufer, T., Sieuwerts, A. M., Talantov, D., Span, P. N., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.9115 · Cited by 361
Support Vector Ordinal Regression
Chu, W., & Keerthi, S. S. (2007) · Neural Computation · doi:10.1162/neco.2007.19.3.792 · Cited by 317
McMillin, D. W., Delmore, J., Weisberg, E., Negri, J. M., Geer, D. C., Klippel, S., Mitsiades, N., Schlossman, R. L., Munshi, N. C., Kung, A. L., et al. (2010) · Nature Medicine · doi:10.1038/nm.2112 · Cited by 315
Wang, F., Hansen, R. K., Radisky, D., Yoneda, T., Barcellos-Hoff, M. H., Petersen, O. W., Turley, E. A., & Bissell, M. J. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1494 · Cited by 270
Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors
Vaira, V., Fedele, G., Pyne, S., Fasoli, E., Zadra, G., Bailey, D., Snyder, E., Faversani, A., Coggi, G., Flavin, R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907676107 · Cited by 267
Self-citationModelling tissues in 3D: the next future of pharmaco-toxicology and food research?
Mazzoleni, G., Di Lorenzo, D., & Steimberg, N. (2009) · Genes & Nutrition · doi:10.1007/s12263-008-0107-0 · Cited by 253
Naba, A., Clauser, K. R., Whittaker, C. A., Carr, S. A., Tanabe, K. K., & Hynes, R. O. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-518 · Cited by 236
An Activated ErbB3/NRG1 Autocrine Loop Supports In Vivo Proliferation in Ovarian Cancer Cells
Sheng, Q., Liu, X., Fleming, E., Yuan, K., Piao, H., Chen, J., Moustafa, Z., Thomas, R. K., Greulich, H., Schinzel, A., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.047 · Cited by 234
Invasive three-dimensional organotypic neoplasia from multiple normal human epithelia
Ridky, T. W., Chow, J. M., Wong, D. J., & Khavari, P. A. (2010) · Nature Medicine · doi:10.1038/nm.2265 · Cited by 217
Weaver, V. M., Lelièvre, S. A., Lakins, J. N., Chrenek, M. A., Jones, J., Giancotti, F. G., Werb, Z., & Bissell, M. J. (2002) · University of North Texas Digital Library (University of North Texas) · doi:10.1016/s1535-6108%2802%2900125-3 · Cited by 208
Chang, J. C., Wooten, E. C., Tsimelzon, A., Hilsenbeck, S. G., Gutierrez, M. C., Tham, Y.-L., Kalidas, M., Elledge, R., Mohsin, S., Osborne, C. K., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.156 · Cited by 197
Collins, K. B., Patterson, B. K., Naus, G. J., Landers, D. V., & Gupta, P. (2000) · Nature Medicine · doi:10.1038/74743 · Cited by 187
Benedettini, E., Sholl, L. M., Peyton, M., Reilly, J., Ware, C., Davis, L., Vena, N., Bailey, D., Yeap, B. Y., Fiorentino, M., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090863 · Cited by 185
Self-citationPontiggia, O., Sampayo, R., Raffo, D., Motter, A., Xu, R., Bissell, M. J., de Kier Joffé, E. B., & Simian, M. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1766-x · Cited by 166
Siu, L. L., Shapiro, J. D., Jonker, D. J., Karapetis, C. S., Zalcberg, J. R., Simes, J. R., Couture, F., Moore, M. J., Price, T. J., Siddiqui, J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.0543 · Cited by 133
Zhang, Z., Dong, Z., Lauxen, I. S., Filho, M. S., & Nor, J. E. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2032 · Cited by 132
Chemotherapy Sensitivity and Resistance Assays: A Systematic Review
Samson, D. J., Seidenfeld, J., Ziegler, K. M., & Aronson, N. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.077 · Cited by 129
Extraction and Assembly of Tissue-Derived Gels for Cell Culture and Tissue Engineering
Uriel, S., Labay, E., Francis-Sedlak, M. E., Moya, M. L., Weichselbaum, R. R., Ervin, N., Cankova, Z., & Brey, E. M. (2008) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2008.0309 · Cited by 123
Yamada, T., Takeuchi, S., Nakade, J., Kita, K., Nakagawa, T., Nanjo, S., Nakamura, T., Matsumoto, K., Soda, M., Mano, H., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2972 · Cited by 122
Hofmann, D., Nitz, U. A., Gluz, O., et al. (2013) · Trials · doi:10.1186/1745-6215-14-261 · Cited by 115
Gerlach, M. M., Merz, F., Wichmann, G., Kubick, C., Wittekind, C., Lordick, F., Dietz, A., & Bechmann, I. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.700 · Cited by 107
Ngoka, L. C. M. (2008) · Proteome Science · doi:10.1186/1477-5956-6-30 · Cited by 107
Karagiannis, G. S., Petraki, C. D., Prassas, I., Saraon, P., Musrap, N., Dimitromanolakis, A., & Diamandis, E. P. (2012) · Oncotarget · doi:10.18632/oncotarget.451 · Cited by 103
“In vitro” 3D models of tumor-immune system interaction
Hirt, C., Papadimitropoulos, A., Mele, V., Muraro, M. G., Mengus, C., Iezzi, G., Terracciano, L., Martín, I., & Spagnoli, G. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.003 · Cited by 94
Zeng, X., Hood, B. L., Sun, M., Conrads, T. P., Day, R., Weissfeld, J. L., Siegfried, J. M., & Bigbee, W. L. (2010) · Journal of Proteome Research · doi:10.1021/pr100696n · Cited by 94
Matzke, M. M., Brown, J. N., Gritsenko, M. A., Metz, T., Pounds, J. G., Rodland, K., Shukla, A. K., Smith, R. D., Waters, K. M., McDermott, J., et al. (2012) · PROTEOMICS · doi:10.1002/pmic.201200269 · Cited by 87
Young, M. R., Petruzzelli, G. J., Kolesiak, K., Achille, N. J., Lathers, D. M. R., & Gabrilovich, D. I. (2001) · Human Immunology · doi:10.1016/s0198-8859(01)00222-1 · Cited by 84
Protein Quantitation Using Mass Spectrometry
Zhang, G., Ueberheide, B. M., Waldemarson, S., Myung, S., Molloy, K. R., Eriksson, J. W., Chait, B. T., Neubert, T. A., & Fenyö, D. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-842-3_13 · Cited by 81
S1P 3 ‐mediated Akt activation and crosstalk with platelet‐derived growth factor receptor (PDGFR)
Baudhuin, L. M., Jiang, Y., Zaslavsky, A., Ishii, I., Chun, J. J. M., & Xu, Y. (2003) · The FASEB Journal · doi:10.1096/fj.03-0302fje · Cited by 76
Independent Prognostic Value of Serum Hepatocyte Growth Factor in Bladder Cancer
Gohji, K., Nomi, M., Niitani, Y., Kitazawa, S., Fujii, A., Katsuoka, Y., & Nakajima, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2963 · Cited by 59
Genovese, L., Zawada, L., Tosoni, A., Ferri, A., Zerbi, P., Allevi, R., Nebuloni, M., & Alfano, M. (2014) · Tissue Engineering Part A · doi:10.1089/ten.tea.2013.0588 · Cited by 58
Opposing Effect of EGFRWT on EGFRvIII-Mediated NF-κB Activation with RIP1 as a Cell Death Switch
Puliyappadamba, V. T., Chakraborty, S., Chauncey, S. S., Li, L., Hatanpaa, K. J., Mickey, B., Noorani, S., Shu, H. G., Burma, S., Boothman, D. A., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.025 · Cited by 43
Jung, P.-S., Kim, D., Kim, M.-B., et al. (2013) · PubMed · Cited by 41
Ashley, N., Jones, M. F., Ouaret, D., Wilding, J., & Bodmer, W. F. (2014) · The Journal of Pathology · doi:10.1002/path.4371 · Cited by 39
The spectra count label-free quantitation in cancer proteomics.
Zhou, W., Liotta, L. A., & Petricoin, E. F. (2012) · PubMed · Cited by 29
Radhakrishnan, P., Ulaganathan, B., Veluchamy, S., Dhandapani, M., Pinto, D. D., Thiyagarajan, S., Thayakumar, A., Prasath, A., Kamal, A., Velu, A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2545 · Cited by 23
Self-citationChemoresponse assay for evaluating response to sunitinib in primary cultures of breast cancer
Suchy, S. L., Hancher, L. M., Wang, D., Ervin, P. R., & Brower, S. L. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.12.15710 · Cited by 6
Cited by
Precision medicine for cancer with next-generation functional diagnostics
Friedman, A. A., Letai, A., Fisher, D. E., & Flaherty, K. T. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4015 · Cited by 570
Screening out irrelevant cell-based models of disease
Horvath, P., Aulner, N., Bickle, M., Davies, A. M., Nery, E. D., Ebner, D., Montoya, M. C., Östling, P., Pietiäinen, V., Price, L. S., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.175 · Cited by 525
Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine
Adir, O., Poley, M., Chen, G., Froim, S., Krinsky, N., Shklover, J., Shainsky‐Roitman, J., Lammers, T., & Schroeder, A. (2020) · Advanced Materials · doi:10.1002/adma.201901989 · Cited by 496
Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
Polak, R., Zhang, E. T., & Kuo, C. J. (2024) · Nature Reviews Cancer · doi:10.1038/s41568-024-00706-6 · Cited by 298
Letai, A., Bhola, P., & Welm, A. L. (2022) · Cancer Cell · doi:10.1016/j.ccell.2021.12.004 · Cited by 281
Metadata
- Authors
- Majumder, B., Baraneedharan, U., Thiyagarajan, S., Radhakrishnan, P., Narasimhan, H., Dhandapani, M., Brijwani, N., Pinto, D. D., Prasath, A., Shanthappa, B. U., Thayakumar, A., Surendran, R., Babu, G. K., Shenoy, A. M., Kuriakose, M. A., Bergthold, G., Horowitz, P., Loda, M., Beroukhim, R., Agarwal, S., Sengupta, S., Sundaram, M., & Majumder, P. K.
- Venue
- Nature Communications
- Published
- 2015-02-27
- Volume
- 6
- Issue
- 1
- Pages
- 6169-6169
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W1963654222
- Cited by
- 308
- References
- 63
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.